Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-20

Clinical Trial Update: Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents [Phase 2]

View source ↗

Summary

This randomized Phase II trial in children and adolescents evaluated the safety and neutralizing activity of CL184 with Rabies Vaccine versus HRIG with Rabies V…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CL184 (CL184)
  • HRIG (human rabies immune globulin)
  • Rabies vaccine (rabies vaccine)

Snippet

Sponsor: Crucell Holland BV | Conditions: Rabies | Phase 2 | Status: COMPLETED